Jonas Oldgren

Uppsala University — Sweden

Medicine · Health Sciences

67h-index52.5kcitations303works60.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atrial Fibrillation Management and Outcomes(200), Cardiac Arrhythmias and Treatments(69), Antiplatelet Therapy and Cardiovascular Diseases(62), Acute Myocardial Infarction Research(49), Venous Thromboembolism Diagnosis and Management(46)

Publications298 total

Coronary Computed Tomography Angiography in Prediction of First Coronary Events
JAMA·2025· 4 citedOpen Access
Abstract 4338221: EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics
Circulation·2025
Prevalence and prediction of masked uncontrolled hypertension in patients recently hospitalized for myocardial infarction
European Heart Journal Open·2025Open Access
Recommended methodologies for clinical investigations of high-risk medical devices—Conclusions from the European Union CORE–MD Project
The Lancet Regional Health - Europe·2025· 3 citedOpen Access
Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study
Circulation·2025· 2 citedOpen Access
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial
Journal of the American Heart Association·2025· 1 citedOpen Access
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)
The Lancet·2025· 17 citedOpen Access
Rationale and design of a registry-based randomized controlled study of personalized biomarker-based risk score-guided stroke prevention treatment in atrial fibrillation
American Heart Journal·2025· 2 citedOpen Access
Associations between physical activity and CVD-related metabolomic and proteomic biomarkers
PLoS ONE·2025· 1 citedOpen Access
Alcohol Intake and Cardiovascular Outcomes in Patients With Atrial Fibrillation: <scp>RE</scp>‐<scp>LY AF</scp> Registry Analysis
Annals of Noninvasive Electrocardiology·2025· 2 citedOpen Access
Prevalence of microspirometry-detected chronic obstructive pulmonary disease in two European cohorts of patients hospitalised for acute myocardial infarction: a cross-sectional study
BMJ Open·2025Open Access
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use
JAMA Cardiology·2025· 2 citedOpen Access
Correction: Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience
Trials·2025Open Access
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation
Journal of the American College of Cardiology·2025· 4 cited
Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience
Trials·2025· 4 citedOpen Access
Abstract 4138781: Neuro-specific biomarkers for risk assessment of ischemic stroke and death in patients with atrial fibrillation not receiving oral anticoagulation
Circulation·2024
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
Journal of the American Heart Association·2024· 2 citedOpen Access
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial
The Lancet·2024· 28 cited
Social differences in subclinical coronary artery atherosclerosis in Sweden
European Heart Journal·2024Open Access
Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline glycaemic status and body mass index: a DAPA-MI substudy
European Heart Journal·2024Open Access
page 1 of 15Next →

Frequent Co-authors

Lars Wallentin(20), Hein Heidbüchel(19), Michael D. Ezekowitz(18), Stuart J. Connolly(17), Salim Yusuf(17), Paul Reilly(16), Paulus Kirchhof(16), John W. Eikelboom(13), Gregory Y.H. Lip(12), Dipak Kotecha(10), A. John Camm(10), Stefan H. Hohnloser(10), Ziad Hijazi(10), Barbara Casadei(9), Ulrich Schotten(9), Hans‐Christoph Diener(8), Dan Atar(8), Panagiotis Vardas(8), Marco Alings(7), Stefano Benussi(7)